Pictet Asset Management’s NovoCure NVCR Stock Holding History

Pictet Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$253K	Sell	16,684 -3,161	-16%	-$47.8K	﹤0.01%	1862
2026 Q1	$216K	Buy	19,845 +3,811	+24%	+$47.6K	﹤0.01%	1901
2025 Q4	$207K	Hold	16,034	–	–	﹤0.01%	1903
2025 Q3	$207K	Sell	16,034 -1,826	-10%	-$24.4K	﹤0.01%	1857
2025 Q2	$318K	Buy	17,860 +1,041	+6%	+$18.1K	﹤0.01%	1598
2025 Q1	$302K	Buy	16,819 +1,900	+13%	+$43.2K	﹤0.01%	1616
2024 Q4	$445K	Buy	14,919 +2,468	+20%	+$52.2K	﹤0.01%	1429
2024 Q3	$195K	Hold	12,451	–	–	﹤0.01%	1826
2024 Q2	$213K	Hold	12,451	–	–	﹤0.01%	1722
2024 Q1	$195K	Hold	12,451	–	–	﹤0.01%	1777
2023 Q4	$186K	Hold	12,451	–	–	﹤0.01%	1773
2023 Q3	$201K	Buy	+12,451	New	+$359K	﹤0.01%	1687

Other funds holding NVCR

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

CMF

Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Pictet Asset Management's NVCR Position: Q2 2026 in Review

Pictet Asset Management reduced its NovoCure (NVCR) stake by 16% in Q2 2026, selling an estimated $47.8K and leaving 16,684 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #1862.

Pictet Asset Management first reported a position in NVCR in Q3 2023 and has held it in 12 quarters since. The position peaked at $445K in Q4 2024. 41 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

Pictet Asset Management held 16,684 shares of NovoCure worth $253K as of Q2 2026.
Pictet Asset Management sold 3,161 NovoCure shares in Q2 2026, an estimated $47.8K.
NovoCure made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1862 holding.
Pictet Asset Management first reported a position in NovoCure in Q3 2023 and has held it in 12 quarters since.
Pictet Asset Management's NovoCure position peaked at $445K in Q4 2024.
41 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.